All Clari (n = 186) | All Cipro (n = 185) | All (n = 371) | |||||||
MAC | M maloense | M xenopi | All 3 species | MAC | M maloense | M xenopi | All 3 species | Total | |
No entered | 83 | 86 | 17 | 186 | 87 | 81 | 17 | 185 | 371 |
No deviated* | 29 (35%) | 21 (24%) | 10 (59%) | 60 (32%) | 37 (43%) | 35 (43%) | 8 (47%) | 80 (43%) | 140 (38%) |
4th drug required (added) | 10 (10) | 3 (3) | 0 | 13 (13) | 15 (13) | 3 (2) | 1 (1) | 19 (16) | 32 (29) |
Deaths from all causes | 40 (48%) | 36 (42%) | 5 (29%) | 81 (44%) | 26 (30%) | 45 (56%) | 8 (47%) | 79 (43%) | 160 (43%) |
Deaths due to mycobacterial disease | 2 | 4 | 0 | 6 | 3 | 2 | 1 | 6 | 12 |
Failures of treatment | 4 (1D) | 1 (1D) | 2 | 7 (2D) | 13 | 4 | 1 | 18 | 25 (2D) |
Relapses | 7 | 3 (1D) | 2 | 12 (1D) | 7 (2D) | 0 | 0 | 7 (2D) | 19 (3D) |
No completed treatment as allocated and alive and cured at 5 years | 20 (24%) | 33 (38%) | 3 (18%) | 56 (30%) | 20 (23%) | 16 (20%) | 2 (12%) | 38 (21%) | 94 (25%) |
No alive and cured at 5 years | 26 (31%) | 42 (49%) | 6 (35%) | 74 (40%) | 30 (34%) | 25 (31%) | 6 (35%) | 61 (33%) | 135 (36%) |
Clari, clarithromycin; Cipro, ciprofloxacilin; D, death due to mycobacterial disease; MAC, Mycobacterium avium intracellulare.
*Reasons for deviation are detailed in the second section of the Results.